Location History:
- Notting, AU (2013)
- Notting Hill, AU (2014 - 2015)
- Alpharetta, GA (US) (2017)
Company Filing History:
Years Active: 2013-2017
Title: Kelly Helen Anderson: Innovator in Viral Infection Treatment
Introduction
Kelly Helen Anderson is a prominent inventor based in Notting Hill, Australia. She has made significant contributions to the field of medicine, particularly in the treatment of viral infections. With a total of five patents to her name, Anderson's work focuses on innovative compounds that target respiratory syncytial virus (RSV) infections.
Latest Patents
Anderson's latest patents include "Substituted imidazo[1,2-d]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections." This invention relates to compounds of formula (I), along with their salts, isomers, or prodrugs, which are useful in treating viral infections, specifically RSV infections. Additionally, she has developed another patent with a similar focus, emphasizing the processes for preparing these compounds and the intermediates used in their preparation.
Career Highlights
Throughout her career, Anderson has worked with notable companies such as Biota Scientific Management Pty Ltd and Biota Europe Limited. Her experience in these organizations has allowed her to advance her research and contribute to the development of effective treatments for viral infections.
Collaborations
Anderson has collaborated with esteemed colleagues, including Jeffrey Peter Mitchell and Alistair George Draffan. These partnerships have further enriched her research and innovation in the field.
Conclusion
Kelly Helen Anderson is a trailblazer in the development of treatments for viral infections, particularly RSV. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.